Park Avenue Securities LLC Vertex Pharmaceuticals Inc Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Park Avenue Securities LLC holds 13,987 shares of VRTX stock, worth $5.74 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

13,987

Previous 13,999 0.09%

Holding current value

$5.74 Million

Previous $6.56 Million 0.87%

% of portfolio

0.07%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$460.0 - $505.78 $5,520 - $6,069	-12 Reduced 0.09%	13,987 $6.51 Million
Q2 2024 Jul 09, 2024	SELL	$392.81 - $485.53 $94,274 - $116,527	-240 Reduced 1.69%	13,999 $6.56 Million
Q1 2024 Apr 10, 2024	BUY	$407.69 - $446.08 $447,235 - $489,349	1,097 Added 8.35%	14,239 $5.95 Million
Q4 2023 Jan 10, 2024	BUY	$343.0 - $410.68 $912,723 - $1.09 Million	2,661 Added 25.39%	13,142 $5.35 Million
Q3 2023 Oct 26, 2023	SELL	$338.18 - $362.46 $152,857 - $163,831	-452 Reduced 4.13%	10,481 $3.65 Million
Q2 2023 Jul 14, 2023	BUY	$314.42 - $351.91 $233,299 - $261,117	742 Added 7.28%	10,933 $3.85 Million
Q1 2023 Apr 18, 2023	BUY	$283.23 - $323.1 $428,526 - $488,850	1,513 Added 17.43%	10,191 $3.21 Million
Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $246,610 - $277,437	863 Added 11.04%	8,678 $0
Q3 2022 Nov 01, 2022	BUY	$273.83 - $305.53 $28,752 - $32,080	105 Added 1.36%	7,815 $2.26 Million
Q2 2022 Jul 27, 2022	SELL	$234.96 - $292.55 $272,318 - $339,065	-1,159 Reduced 13.07%	7,710 $2.17 Million
Q1 2022 Apr 29, 2022	BUY	$221.42 - $260.97 $673,338 - $793,609	3,041 Added 52.18%	8,869 $2.32 Million
Q4 2021 Apr 08, 2022	SELL	$177.01 - $223.45 $181,081 - $228,589	-1,023 Reduced 14.93%	5,828 $1.28 Million
Q3 2021 Oct 21, 2021	SELL	$181.39 - $202.99 $782,516 - $875,698	-4,314 Reduced 38.64%	6,851 $1.24 Million
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $70,871 - $83,575	-378 Reduced 3.27%	11,165 $2.25 Million
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $964,920 - $1.12 Million	4,661 Added 67.73%	11,543 $2.48 Million
Q4 2020 Jan 20, 2021	BUY	$207.01 - $276.09 $405,532 - $540,860	1,959 Added 39.79%	6,882 $1.63 Million
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $201,963 - $239,449	790 Added 19.11%	4,923 $1.34 Million
Q2 2020 Jul 30, 2020	BUY	$225.48 - $295.8 $55,242 - $72,471	245 Added 6.3%	4,133 $1.2 Million
Q1 2020 Apr 28, 2020	BUY	$199.77 - $247.81 $87,099 - $108,045	436 Added 12.63%	3,888 $925,000
Q4 2019 Feb 04, 2020	SELL	$166.71 - $223.91 $2,000 - $2,686	-12 Reduced 0.35%	3,452 $756,000
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $20,113 - $22,637	121 Added 3.62%	3,464 $587,000
Q2 2019 Jul 26, 2019	BUY	$164.61 - $190.37 $550,291 - $636,406	3,343 New	3,343 $613,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Vertex Pharmaceuticals Inc Transaction History